| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/23/2003 | EP1235842A4 Rna interference pathway genes as tools for targeted genetic interference |
| 04/23/2003 | EP1016714B1 Novel plasmid dna containing reporter gene dna and use of the same |
| 04/23/2003 | EP0880536B1 Process for preparing purified nucleic acid and the use thereof |
| 04/23/2003 | EP0817858B1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 04/23/2003 | CN1413258A Invasive bacterial vectors for expressing alphavirus replicons |
| 04/23/2003 | CN1413251A Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, DNA encoding this protein and gene remedies containing the same |
| 04/23/2003 | CN1413249A Human heparanase-related polypeptide and nucleic acid |
| 04/23/2003 | CN1413230A Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/23/2003 | CN1412295A Oncolytic microorganism expressing heat shock protein and its application |
| 04/23/2003 | CN1106447C Human tree protuberant cytoma immuno-therapeutic preparation for oriented proliveration and expression interleukin 12 and its preparation method |
| 04/22/2003 | US6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof |
| 04/22/2003 | US6552005 Treating with the adenovirus encoding cytosine deaminase gene and uracil phosphoribosyltranserase gene; administering 5-fluorocytosine; therapy with radiation |
| 04/22/2003 | US6552003 Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF |
| 04/22/2003 | US6551996 Super-active porcine growth hormone releasing hormone analog |
| 04/22/2003 | US6551989 Preventing airway mucus production by administration of EGF-R antagonists |
| 04/22/2003 | US6551792 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy |
| 04/22/2003 | US6551618 Compositions and methods for delivery of agents for neuronal regeneration and survival |
| 04/22/2003 | US6551595 Smallpox inhibitor of complement enzymes (SPICE) protein and methods of inhibiting complement activation |
| 04/22/2003 | US6551588 Administering at or around the solid tumor an expressible nucleic acid encoding interleukin-3, and providing a tumor antigen, then treating the tumor with radiotherapy |
| 04/22/2003 | US6551587 Tissue-specific taanscriptional regulatory sequence operably linked to the coding region of a gene that is essential for replication of said vector. |
| 04/22/2003 | CA2152941C Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 04/17/2003 | WO2003031932A2 Methods and compositions for detecting colon cancers |
| 04/17/2003 | WO2003031633A2 Adenoviral vector system |
| 04/17/2003 | WO2003031630A1 Multi-cistronic vectors for gene transfer protocols |
| 04/17/2003 | WO2003031602A1 The oncolytic microorganisms expressing hsp and uses thereof |
| 04/17/2003 | WO2003031598A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 04/17/2003 | WO2003031594A2 Nucleotide and amino acid sequences relating to respiratory diseases and obesity |
| 04/17/2003 | WO2003031588A2 Hepatitis c virus vaccine |
| 04/17/2003 | WO2003031584A2 Axon repair |
| 04/17/2003 | WO2003031477A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 04/17/2003 | WO2003031476A1 Antibody of human origin for inhibiting thrombocytes aggregation |
| 04/17/2003 | WO2003031459A2 Modulation of the expression of genes dependent on stat-1 |
| 04/17/2003 | WO2003030946A1 Regulation of insulin production |
| 04/17/2003 | WO2003030945A1 Cationic lipids suitable for gene transfer |
| 04/17/2003 | WO2003030944A2 Inhibition of stat-1 |
| 04/17/2003 | WO2003030943A1 Compositions comprising hydroxyapatite useful for the administration of therapeutic agents |
| 04/17/2003 | WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | WO2003030936A1 Remedies for life style-related diseases or cibophobia and method of screening the same |
| 04/17/2003 | WO2003030935A2 Adjuvants for nucleic acid vaccines |
| 04/17/2003 | WO2003030934A2 Cpg formulations and related methods |
| 04/17/2003 | WO2003030922A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 04/17/2003 | WO2003030827A2 Compositions for and methods of treating and preventing sirs/sepsis |
| 04/17/2003 | WO2003030826A2 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 04/17/2003 | WO2003030725A2 Pancreatic cancer diagnosis and therapies |
| 04/17/2003 | WO2003030720A2 Materials and methods for preventing or reducing scar formation |
| 04/17/2003 | WO2003030719A2 Methods and kits for use in selecting approaches to treating cancer |
| 04/17/2003 | WO2003030616A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 04/17/2003 | WO2003030612A2 Methods for modulating activity of the fxr nuclear receptor |
| 04/17/2003 | WO2002094863A3 INTERFERON-α INDUCED GENE |
| 04/17/2003 | WO2002086064A3 Inducible expression of transfected genes |
| 04/17/2003 | WO2002083727A3 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 04/17/2003 | WO2002081726A3 Modulation of gene expression in mouse genetic models of atherosclerosis |
| 04/17/2003 | WO2002081706A3 Regulation of human phosphatase-like protein |
| 04/17/2003 | WO2002058718A3 Use of compositions containing pdgf-bb for promoting angiogenesis |
| 04/17/2003 | WO2002053752A3 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 04/17/2003 | WO2002051237A9 Helicobacter proteins, nucleic acids and uses thereof |
| 04/17/2003 | WO2002050284A3 Oxidoreductases |
| 04/17/2003 | WO2002030974A3 Proteins and nucleic acids encoding same |
| 04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
| 04/17/2003 | WO2002012341A3 Her-2/neu fusion proteins |
| 04/17/2003 | WO2002010402A3 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 04/17/2003 | WO2002004511A3 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 04/17/2003 | WO2001072773A3 Genes isolated from dendritic cells, gene products and methods employing the same |
| 04/17/2003 | US20030074691 Resistance to viruses and viroids in transgenic plants and animals expressing dsRNA-binding protein |
| 04/17/2003 | US20030074680 Generation of animal food products having amplified ribs; obtain embryos, transform with vector, implant embryo into mammal, test progeny for expression of transgene, process progeny for food |
| 04/17/2003 | US20030074679 Administration of nucleic acid sequence to female animal to enhance growth in offspring |
| 04/17/2003 | US20030074024 System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 04/17/2003 | US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | US20030073823 Polypeptide for use in the treatment of cancer, cardiovasular disease, and immunological disorders |
| 04/17/2003 | US20030073822 Blood group antigen fusion polypeptides and method of use thereof |
| 04/17/2003 | US20030073819 PGC-1, a novel brown fat PPARgamma coactivator |
| 04/17/2003 | US20030073660 Anticancer agents; blood disorders |
| 04/17/2003 | US20030073659 Encapsulation of virus; genetic engineering; packaging signal |
| 04/17/2003 | US20030073657 Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an ACT polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances |
| 04/17/2003 | US20030073655 Alzheimer's disease |
| 04/17/2003 | US20030073653 Method for transferring nucleic acid into striated muscles |
| 04/17/2003 | US20030073652 Ex-vivo and in vivo factor XII gene therapy for hemophilia A and B |
| 04/17/2003 | US20030073624 Anticancer agents; isolated nucleic acids; genetic engineering |
| 04/17/2003 | US20030073620 Genetic engineering; antibody binding to nucleic acid; disease therapy |
| 04/17/2003 | US20030073619 Branched polyethylenimine |
| 04/17/2003 | US20030073238 Apparatus and method for electroporation of biological samples |
| 04/17/2003 | US20030073167 DNA encoding SNORF36 receptors |
| 04/17/2003 | US20030073123 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition |
| 04/17/2003 | US20030073084 ING-encoded p33ING1 protein as a mediator of p53 signaling pathway in mammalian cells |
| 04/17/2003 | US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development |
| 04/17/2003 | US20030073076 Analyzing modulators or treatments of fibroproliferative diseases; obtain sample, incubate with modulator, monitor marker expression, decreased expression indicate effective modulator |
| 04/17/2003 | US20030072796 For activating T lymphocytes in vitro for the treatment of disease conditions |
| 04/17/2003 | US20030072769 Used in the manufacture of vaccines, therapy, prophylaxis, drug screening |
| 04/17/2003 | US20030072768 Method to enhance an immune response of nucleic acid vaccination |
| 04/17/2003 | US20030072767 Compositions and methods for WT1 specific immunotherapy |
| 04/17/2003 | US20030072764 Mucosal boosting following parenteral priming |
| 04/17/2003 | US20030072762 For enhancing Fc receptor-mediated antigen presentation, vaccines |
| 04/17/2003 | US20030072752 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/17/2003 | US20030072749 Applying at least one chondroitin sulfate proteoglycan-degrading enzyme to the damaged nerve for promoting repair of a damaged nerve |
| 04/17/2003 | US20030072744 Delivering a vector to the heart of patient, vector comprising a transgene coding for a cardiomyocyte-differentiating peptide for improving or maintaining cardiac function |
| 04/17/2003 | US20030072742 Enhancement of immune response using targeting molecules |
| 04/17/2003 | US20030072736 Human tumor necrosis factor receptor TR16 |
| 04/17/2003 | CA2718802A1 Recombinant nucleic acids comprising regions of ad6 |
| 04/17/2003 | CA2471968A1 Immunostimulatory nucleic acids and use thereof |
| 04/17/2003 | CA2464662A1 Modulation of the expression of genes dependent on stat-1 |